Back
Verrica Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
17
VRCA
Verrica Pharmaceuticals
Last Price:
0.72
Seasonality Move:
31.35%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
Verrica Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.35 | Sell |
| 20-day SMA: | 1.41 | Sell |
| 50-day SMA: | 1.66 | Sell |
| 200-day SMA: | 5.29 | Sell |
| 8-day EMA: | 1.22 | Sell |
| 20-day EMA: | 1.4 | Sell |
| 50-day EMA: | 2.08 | Sell |
| 200-day EMA: | 4.38 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 26.76 | Sell |
| Chaikin Money Flow: | -1643816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.61) | Sell |
| Bollinger Bands (100): | (1.3 - 6.68) | Sell |
Verrica Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.75 while VRCA 8-day simple moving average is 1.35, which is a Sell signal.
- The stock price of VRCA is 0.75 while Verrica Pharmaceuticals 20-day SMA is 1.41, which makes it a Sell.
- Verrica Pharmaceuticals 50-day simple moving average is 1.66 while VRCA share price is 0.75, making it a Sell technically.
- VRCA stock price is 0.75 and Verrica Pharmaceuticals 200-day simple moving average is 5.29, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
17
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Sell
The current Verrica Pharmaceuticals [VRCA] share price is $0.75. The Score for VRCA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
34.03M
Price in USD:
0.75
Share Volume:
1.79M
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.75
Sell
17
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 0.75 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.75 while VRCA 8-day exponential moving average is 1.22, which is a Sell signal.
- The stock price of VRCA is 0.75 while Verrica Pharmaceuticals 20-day EMA is 1.40, which makes it a Sell.
- Verrica Pharmaceuticals 50-day exponential moving average is 2.08 while VRCA share price is 0.75, making it a Sell technically.
- VRCA stock price is 0.75 and Verrica Pharmaceuticals 200-day simple moving average is 4.38, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.74 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Verrica Pharmaceuticals is a Sell
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 26.76, which suggest Verrica Pharmaceuticals is oversold
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (1.17 - 1.61), which suggest Verrica Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (1.3 - 6.68), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.